Search research articles
Contact Us
Filters
Showing results (291-300 of 387) with videos related to
Page
of 39
Sort By:
American Journal of Hematology
|
April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
Clive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Blood Cancer Journal
|
May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts
Sanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
Blood Cancer Journal
|
March 27, 2021
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
Jennifer J Gile, Camden L Lopez, Gordon J Ruan, et al.
Hematological Oncology
|
August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type
Robert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Iscience
|
June 1, 2023
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiaosheng Wu, Michelle K Manske, Gordon J Ruan, et al.
Cancer Research
|
April 19, 2007
Proteomic analysis of waldenstrom macroglobulinemia
Evdoxia Hatjiharissi, Hai Ngo, Alexey A Leontovich, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 387) with videos related to
Sort By:
Page
of 39
American Journal of Hematology
|
April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
Clive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study
Megan M Garrity, Lawrence J Burgart, Michelle R Mahoney, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
The Oncologist
|
September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
Paul J Hampel, Timothy G Call, Kari G Rabe, et al.
Blood Cancer Journal
|
May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts
Sanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
Blood Cancer Journal
|
March 27, 2021
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
Jennifer J Gile, Camden L Lopez, Gordon J Ruan, et al.
Hematological Oncology
|
August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type
Robert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Iscience
|
June 1, 2023
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiaosheng Wu, Michelle K Manske, Gordon J Ruan, et al.
Cancer Research
|
April 19, 2007
Proteomic analysis of waldenstrom macroglobulinemia
Evdoxia Hatjiharissi, Hai Ngo, Alexey A Leontovich, et al.
Page
of 39